Andrej Jedinak, PhD Consulting Services

Dr. Jedinak’s ability to bridge preclinical findings with clinical applications is exactly what our biotech firm needed during our last drug discovery phase. His expertise spans multiple therapeutic areas, including oncology and immunology, which allowed us to refine our target identification strategy effectively. While the scientific guidance was exceptional, I would have appreciated more detailed breakdowns of the service deliverables in the initial proposal phase to better align our internal resources. Nevertheless, the strategic value provided during the consultation was significant, and the response time was prompt. It is clear that the consulting team understands the complexities of translational science and can offer genuine insights that accelerate development pipelines for pharma organizations looking to innovate.

The scientific depth available through this consulting practice is genuinely impressive, particularly regarding rare metabolic diseases and target validation. From the information available, the transition from academic rigor to industry application seems well-supported. However, the lack of clear pricing structures in the public materials means prospective clients should be prepared to discuss budget expectations early in the consultation process.

I really enjoyed working with Dr. Jedinak on our immuno-oncology program. His background at Harvard and his hands-on experience with RNAi and gene therapy approaches gave us a lot of confidence. The process was smooth, from the free intro call to the custom proposal. It feels like having a seasoned expert on the team without the full-time overhead. Highly recommend for anyone needing strategic scientific input.